Geode Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Geode Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$305K	Buy	10,150 +2,299	+29%	+$76.1K	﹤0.01%	3769
2025 Q4	$257K	Hold	7,851	–	–	﹤0.01%	3828
2025 Q3	$272K	Hold	7,851	–	–	﹤0.01%	3834
2025 Q2	$220K	Buy	+7,851	New	+$210K	﹤0.01%	3845
2025 Q1	–	Sell	-7,819	Closed	-$215K	–	4491
2024 Q4	$215K	Hold	7,819	–	–	﹤0.01%	3879
2024 Q3	$225K	Sell	7,819 -4,271	-35%	-$116K	﹤0.01%	3865
2024 Q2	$300K	Hold	12,090	–	–	﹤0.01%	3769
2024 Q1	$389K	Buy	12,090 +1,095	+10%	+$40.7K	﹤0.01%	3698
2023 Q4	$447K	Buy	10,995 +900	+9%	+$33.1K	﹤0.01%	3657
2023 Q3	$349K	Hold	10,095	–	–	﹤0.01%	3750
2023 Q2	$410K	Hold	10,095	–	–	﹤0.01%	3722
2023 Q1	$390K	Hold	10,095	–	–	﹤0.01%	3741
2022 Q4	$448K	Hold	10,095	–	–	﹤0.01%	3706
2022 Q3	$430K	Hold	10,095	–	–	﹤0.01%	3797
2022 Q2	$563K	Buy	10,095 +3,988	+65%	+$236K	﹤0.01%	3700
2022 Q1	$378K	Sell	6,107 -5	-0.1%	-$306	﹤0.01%	4078
2021 Q4	$336K	Buy	6,112 +2,085	+52%	+$109K	﹤0.01%	4240
2021 Q3	$211K	Buy	4,027 +132	+3%	+$7.84K	﹤0.01%	4425
2021 Q2	$268K	Sell	3,895 -925	-19%	-$70.5K	﹤0.01%	4214
2021 Q1	$371K	Buy	4,820 +222	+5%	+$20.5K	﹤0.01%	3910
2020 Q4	$455K	Sell	4,598 -2,273	-33%	-$278K	﹤0.01%	3620
2020 Q3	$975K	Buy	6,871 +368	+6%	+$61.4K	﹤0.01%	3220
2020 Q2	$1.28M	Sell	6,503 -488	-7%	-$101K	﹤0.01%	3064
2020 Q1	$1.37M	Sell	6,991 -4,974	-42%	-$1.07M	﹤0.01%	2878
2019 Q4	$2.47M	Buy	11,965 +6,223	+108%	+$1.15M	﹤0.01%	2883
2019 Q3	$876K	Hold	5,742	–	–	﹤0.01%	3275
2019 Q2	$740K	Hold	5,742	–	–	﹤0.01%	3326
2019 Q1	$676K	Hold	5,742	–	–	﹤0.01%	3311
2018 Q4	$526K	Hold	5,742	–	–	﹤0.01%	3357
2018 Q3	$645K	Hold	5,742	–	–	﹤0.01%	3373
2018 Q2	$529K	Sell	5,742 -196	-3%	-$19K	﹤0.01%	3423
2018 Q1	$592K	Hold	5,938	–	–	﹤0.01%	3344
2017 Q4	$556K	Hold	5,938	–	–	﹤0.01%	3315
2017 Q3	$604K	Buy	5,938 +1,360	+30%	+$119K	﹤0.01%	3296
2017 Q2	$350K	Sell	4,578 -479	-9%	-$40.3K	﹤0.01%	3493
2017 Q1	$435K	Buy	5,057 +466	+10%	+$33.6K	﹤0.01%	3357
2016 Q4	$294K	Buy	4,591 +910	+25%	+$56K	﹤0.01%	3461
2016 Q3	$238K	Buy	3,681 +27	+0.7%	+$1.52K	﹤0.01%	3538
2016 Q2	$202K	Buy	+3,654	New	+$184K	﹤0.01%	3590
2016 Q1	–	Sell	-3,353	Closed	-$210K	–	4106
2015 Q4	$210K	Buy	+3,353	New	+$171K	﹤0.01%	3666

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management's LKFT Position: Q1 2026 in Review

Geode Capital Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 29% in Q1 2026, buying an estimated $76.1K and bringing the position to 10,150 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

Geode Capital Management first reported a position in LKFT in Q4 2015 and has held it in 40 quarters since. The position peaked at $2.47M in Q4 2019. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Geode Capital Management held 10,150 shares of Lakefront Biotherapeutics American Depositary Shares worth $305K as of Q1 2026.
Geode Capital Management bought 2,299 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $76.1K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3769 holding.
Geode Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and has held it in 40 quarters since.
Geode Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.47M in Q4 2019.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.